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Abstract Vitamin D deficiency is associated with secondary
hyperparathyroidism, increased bone turnover, and bone loss,
leading to increased risk for osteoporotic fractures. The
objective of this study was to investigate the prevalence of
inadequate (insufficient or deficient) serum vitamin D levels
in Croatian postmenopausal women initially screened for
osteoporosis. Assessment of 25-hydroxyvitamin D (25(OH)
D) was performed in 120 Croatian postmenopausal women
aged ≥50 years. Three cut-off levels of vitamin D inadequacy
were investigated: <75, <50, and <30 nmol/L. Among the
included patients, only 14.2% of women complied with
diagnostic criteria for osteoporosis. A total of nine (7.5%)
had vitamin D levels greater than 75 nmol/L, suggesting that
92.5% of postmenopausal women had inadequate vitamin D
status. The prevalence of two different cut-off point groups
was 63.3% (<50 nmol/L) and 14.2% (<30 nmol/L). Mean
(±SD) serum level of 25(OH)D was 46.94 (16.77) nmol/L.
Vitamin D was exhibiting declining values with increasing
age (r=−0.28; P=0.002). The prevalence of vitamin D levels
below 30 nmol/L was high in patient aged ≥65 years
(23.8%). The highest mean level of vitamin D was detected
in summer, with significant differences from spring and
winter (P=0.015 and P=0.022, respectively). The results of
this study indicate a high prevalence of vitamin D inadequa-
cy in Croatian postmenopausal women initially screened for
osteoporosis. High prevalence coupled with the rising
recognition of potential clinical significance of the vitamin
D inadequacy makes this highly interesting intervention
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target, suggesting that the attempts to increase the awareness
on this issue are needed.
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Introduction
The past decade was marked by the increasing interest in
vitamin D and its physiological functions. Results of
various studies implicated that vitamin D has an important
role in the skeletal and some nonskeletal functions in the
human organism. Several stages of the lack of vitamin D
were described, ranging from insufficiency to deficiency.
Vitamin D insufficiency was described to cause an increase
in the serum levels of parathyroid hormone (PTH), leading
to increased bone resorption and consequently even
osteoporosis. Severe vitamin D deficiency is known to
cause rickets or osteomalacia. Poor vitamin D status in the
body has also been implicated as a contributing factor to
muscle weakness and propensity to falls, which together
with negative influences on bone mineral density (BMD)
increases the risk for osteoporotic fractures [1–4].
Vitamin D inadequacy has potential effects on other
organ systems [5]. Presence of vitamin D receptor is
detected in many tissues not directly involved in mineral
metabolism. Adequate vitamin D status has been positively
associated with better physical performance [6–8], lower
cancer incidence and mortality [9, 10], decreased risk of
cardiovascular and autoimmune diseases (such as diabetes
type 1, multiple sclerosis, and rheumatoid arthritis) [11],
and has beneficial effects in prevention of infection [5].
There are two main sources of the vitamin D in the
organism. It can be obtained through the diet (plants are the
source of the ergocalciferol, vitamin D2, while oily fish are
the source of cholecalciferol, vitamin D3), or it can be
synthesized in the skin, after exposure to the sun (vitamin
D3). After hydroxylation in the liver into 25-hydroxyvitamin
D (25(OH)D), second hydroxylation occurs in kidney into
1,25-dihidroxyvitamin D (1,25(OH)2D), forming the active
metabolite which stimulates the calcium absorption from the
gut [12].
25(OH)D is the main circulating metabolite of vitamin
D, and it is considered as good indicator of the global
vitamin D status in the body. Serum concentration of 25
(OH)D is under predominant influence of solar ultraviolet
B (UVB) radiation (wavelength from 290 to 315 nm) [12].
There are no universally established guidelines as to
which levels of 25(OH)D constitute adequacy. According to
most surveys, adequate or sufficient vitamin D concentra-
tion is that equal or greater than 75 nmol/L (30 ng/ml),
which is the lowest concentration of vitamin D able to
prevent rise of PTH and may be necessary to optimize bone
health. Concentrations between 50 and 75 nmol/L (20 and
30 ng/ml) are considered as vitamin D insufficiency, while
concentrations below 50 nmol/L (20 ng/ml) are considered as
vitamin D deficiency [13–15]. To assure bone health serum,
25(OH)D concentrations should be at least 50 nmol/L, which
represents therapeutic target. Observational studies suggest
that the optimal serum 25(OH)D level for nonskeletal
benefits is greater than 75 nmol/L [16]. Additionally,
previous studies have demonstrated that vitamin D status
depends on the age, gender, and skin color and has a strong
seasonal variation. Thus, old age, female sex, darker skin
pigmentation, less sunlight exposure, improper dietary
habits, and absence of vitamin D fortification are the main
factors that are associated with lower 25(OH)D levels [17,
18]. All these results suggest that the possible extent of the
25(OH)D inadequacy may be greater than it was initially
expected. Previous studies have demonstrated that the
vitamin D status often shows inadequate levels in various
populations, making this one of the highly interesting public
health targets [18, 19].
The aim of this study was to investigate the prevalence
of inadequate (insufficient or deficient) serum vitamin D
levels in Croatian postmenopausal women, who were
screened for osteoporosis.
Materials and methods
This study was based on the sample of adult, postmeno-
pausal women (aged 50 years or over) from Croatia. Croatia
is a European country located in southeast of Europe
(latitude from 42° to 46°) with 4.7 million inhabitants. This
study took place in Zagreb University Hospital Centre. We
invited those patients for participation who were referred to
our outpatient clinic for initial screening for osteoporosis.
The patients were consecutively enrolled, with no influence
on the referral by any of the researchers.
Women were eligible for this study if they had been
postmenopausal for at least 1 year. Menopause was
determined as the cessation of menstrual period either
naturally or caused by bilateral ovariectomy. Women who
previously received therapy for osteoporosis (bisphospho-
nates, strontium ralenate, selective estrogen receptor mod-
ulator, PTH, and hormone replacement therapy) were
excluded from the study. Potential participants were
ineligible if they had significant renal, hepatic, or bowel
dysfunction (inflammatory bowel disease and malabsorp-
tion) and if they had uncontrolled thyroid or parathyroid
gland dysfunction. After receiving information from the
investigator, and being able to ask questions regarding all
aspects of the study, all participants provided written
informed consent before enrolment. The study was ap-
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proved by the Ethical Board of the University Hospital
Center-Zagreb, Zagreb, Croatia.
Fasting blood samples were centrally analyzed. Enzyme-
linked immunosorbent assay was used for assessment of 25
(OH)D. Commercial immunodiagnostic kit (immunodiag-
nostic systems-IDS Ltd, from UK represented by IASON
Zagreb d.o.o, Croatia) with direct assay technology was
used eliminating the inconvenience of solvent precipitation
and centrifugation. It enables quantitative determination of
25(OH)D (vitamin D2 and D3) in human serum or plasma
with very high sensitivity (5 nmol/L from a small sample
size) and good assay precision (intra-assay variability, <8%;
inter-assay variability, <10%) and has wide measuring
range (6–360 nmol/L).
Three different cut-off values of 25(OH)D inadequacy
were assigned: <75, <50, and <30 nmol/L. Values of 25
(OH)D ≥75 nmol/L were considered as sufficient or
adequate, indicating normal vitamin D status.
Additionally, BMD was measured to all patients. BMD
at the lumbar spine (L1–L4) and proximal femur (total hip
and femoral neck) was measured by dual-energy x-ray
absorptiometry using a Delphi W (S/N 700483) instrument
(Hologic, Inc., Waltham, MA, USA). BMD measurements
were converted into T-scores. According to the World
Health Organization guidelines, osteoporosis was defined
as a value for BMD that is 2.5 standard deviations (SDs) or
more below the young adult mean value for women (T-
score ≥−2.5 SD), and osteopenia is defined as a T-score that
lies between −1 and −2.5 SD.
All participants were asked about their physical activity
in the past year if they are independent in activities of daily
living and if they usually spend some time of the day
outdoors. They were also asked about their smoking habits
and educational level.
Statistical analysis
The data were presented as the absolute numbers and
percentages for categorical variables, and averages and
means for numerical data. Independent samples t test was
used for the analysis of the numerical values in two
investigated groups, while the analysis of variance was
used if more than two groups were analyzed, with Tukey's
post hoc test. The correlations were calculated using the
Pearson's test. The critical age for the decline in vitamin D
was calculated using the classification tree with age as a
predictor and vitamin D concentration as the outcome
variable (age was forced into the model, in order to classify
even in case there are no significant cut-off points). The
model was set at ten cross-validations and was based on
the Chi-squared automatic interaction detector algorithm.
The analysis was performed using Statistical Package for
Social Sciences (SPSS) version 13, with significance set at
P<0.05. Odds ratios for hypovitaminosis D across age
groups were calculated by comparing the two elderly
groups of examinees (60–69 and ≥70 years) with the
youngest group (50–59 years). In case of the eldest group,
since all cases had recorded hypovitaminosis, Peto odds
ratio was calculated. This approach allows the calculation
even if the cell frequency in one cell is zero, and it is
suitable for unmatched case control studies [20]. The
analysis was performed using SPSS version 13 (SPSS Inc,
Chicago, IL, USA), with significance set at P<0.05.
Results
A total of 120 postmenopausal women were included in
this study with an average age of 61 years (Table 1).
Average menopause duration was slightly over 10 years
(Table 1). Majority of women had osteopenia or normal
BMD, while only 14.2% of women had osteoporosis
(Table 1). The average BMI was 28.8 kg/m2 (Table 1).
All participants were independent in activities of daily
living, and they usually spend some time of the day
outdoors (data not shown). Most of participants were
physically active in the past year (77.5%); thus, only
22.5% of them reported sitting as predominant type of daily
activity last year. Mean serum concentration of 25(OH)D
was below 50 nmol/L (46.94±16.77; Table 1).
The prevalence of 25(OH)D inadequacy among Croatian
postmenopausal women was 92.5%, 63.3%, and 14.2%
considering cut-offs of 75, 50, and 30 nmol/L (Table 2). All
women with osteoporosis had inadequate 25(OH)D levels
(<75 nmol/L; Table 2).
Vitamin D concentration declined with increasing age
(Fig. 1); thus, correlation between age and serum 25(OH)D
concentration was significant and negative (r=−0.28; P=
0.002). The critical age at which the concentration declined
most strongly was 59 years, with an average value of mean
(±SD) 50.95±17.40 nmol/L for those who were younger or
equal to 59 years and 41.87±14.34 nmol/L for those who
were older than the critical age (t=3.11, P=0.002). When
all patients were divided in three age groups (50–59, 60–69,
and ≥70 years), 25(OH)D concentration differed signifi-
cantly across the entire sample (F=7.05; P=0.001), being
the lowest in group of patient aged 70 years or more
(Table 3). Prevalence of vitamin D inadequacy was
significantly higher in the eldest age group compared to
the youngest age group (Fisher's exact test, P=0.010;
Fig. 2). When considering only patients aged 65 years and
more vs. the rest of the sample, prevalence of vitamin D
deficiency reached 23.8% and 73.8% vs. 14.2% and
63.3% (cut-off of 30 and 50 nmol/L), and prevalence of
vitamin D insufficiency reached 100% vs. 92.5% (cut-off
of 75 nmol/L).
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The analysis of the seasonal pattern of vitamin D was
performed using season rather than the month as the
analyzed variable, due to the insufficient sample size for
more detailed analysis. When all patients were divided into
the four groups based on either spring, summer, autumn, or
winter, measurement of vitamin D suggested significant
differences across the entire sample (F=4.03, P=0.009),
while the post hoc test indicated significant differences
between spring and summer (P=0.015) and winter and
summer (P=0.022), while the remaining pairwise compar-
isons were insignificant. The averages and SDs for the
measured vitamin D concentrations were as follows: spring
Characteristic Mean ± SD Range N %
Age (years) 61.19±8.84 50–88
Years since menopause (years) 11.40±8.89 1–44
Body weight (kg) 74.80±12.02 49.0–114.2
Body height (cm) 161.1±6.8 140.0–185.0
Body mass index (kg/m2) 28.86±4.74 19.1–44.0
Serum 25-hydroxyvitamin D (nmol/L) 46.94±16.77 10.0–110.9
Serum calcium (mmol/L) 2.43±0.10 2.15–2.73
Lumbar BMD (g/cm2) 1.01±0.18 0.60–1.46
Lumbar BMD (T-score) −0.65±1.43 −3.9–2.4
Femoral neck BMD (g/cm2) 0.83±0.15 0.59–1.32
Femoral neck BMD (T-score) −0.50±1.18 −3.3–3.9
Total hip BMD (g/cm2) 0.95±0.15 0.65–1.45
Total hip BMD (T-score) −0.06±1.22 −2.9–4.1
Bone mineral density status
Osteoporosis 17 14.2
Osteopenia 44 36.6
Normal BMD 59 49.2
Physical activity in the past year
Predominately sitting 27 22.5
Predominately standing or walking 87 72.5
Predominately climbing or lifting 5 4.2
Predominately hard physical work 1 0.8
Smoking
Never smoked 100 83.3
Past smoker 7 5.8
Current smoker 13 10.9
Education level
Without primary school 1 0.8
Primary school 47 39.2
Secondary school 60 50.0
College or faculty 12 10.0
Total 120 100.0
Table 1 The basic characteris-
tics of the 120 Croatian post-
menopausal women
Vitamin D group All patients Patients with osteoporosis Patients with osteopenia or normal BMD
N=120 N=17 N=103
N % N % N %
<30 nmol/L 17 14.2 5 29.4 12 11.7
<50 nmol/L 76 63.3 12 70.6 64 62.1
<75 nmol/L 111 92.5 17 100.0 94 91.3
≥75 nmol/L 9 7.5 0 0.0 9 8.7
Table 2 Prevalence of vitamin
D inadequacy among Croatian
postmenopausal women
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41.35±15.82, summer 54.51±18.85, autumn 45.87±13.62,
and winter 43.38±14.78. Thus, highest level of vitamin D
was detected in summer.
We did not detect a significant correlation between BMI
and serum 25(OH)D concentration (r=−0.13, P=0.157).
Discussion
The results of this study show rather high prevalence of the
vitamin D inadequacy in Croatian postmenopausal women.
This is interesting especially as the vitamin D concen-
trations seem to have different and sometimes unexpected
patterns across various populations. The highest prevalence
of vitamin D deficiency (levels below 25 nmol/L) was
reported in South Asia and Middle East [18, 19], while
Scandinavian countries within Europe have the highest
concentrations, and the Southern Europe the lowest,
contrary to what should be expected [19, 21]. This is
probably caused by different exposure to sunshine, differ-
ences in the dietary intake of vitamin D, and the use of
supplements. Difference in vitamin D status of postmeno-
pausal women within European countries was confirmed in
the recent study [22]. In that study, assessment of 25(OH)D
was performed in 8,532 postmenopausal women with
osteoporosis and osteopenia from nine European countries.
Mean concentration of 25(OH)D was 61.2±27.2 nmol/L,
with the lowest concentration detected in France and
the highest in Spain. There was highly significant differ-
ence in 25(OH)D levels across all nine European countries
(P>0.001). In the whole study population, the prevalence
of vitamin D deficiency (levels below 50 nmol/L) was
32.1% [22].
In the study of Kraljevic et al., very high prevalence
(97%) of vitamin D inadequacy was detected (levels
below 75 nmol/L) in Croatian postmenopausal women
receiving osteoporosis therapy (N=75) [23]. A total of
75% of women had vitamin D deficiency (levels below
50 nmol/L). Our study indicates a similar and high
prevalence of vitamin D inadequacy in Croatian postmen-
opausal women who were initially screened for osteopo-
rosis. The prevalence of 25(OH)D insufficiency (levels
below 75 nmol/L) was 92.5%. The prevalence of vitamin
D deficiency (levels below 50 nmol/L) was 63.3%, and the
prevalence of more pronounced deficiency of vitamin D
(levels below 30 nmol/L) was 14.2%, all being much
higher than in most European countries. In only 14% of
women, osteoporosis was detected which is rather low
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Fig. 2 Effect of age on prevalence of vitamin D inadequacy
Fig. 1 Effect of age on serum 25(OH)D concentration. Dashed line is
the quadratic trend line, showing progressively decreasing vitamin D
concentrations with increasing age
Table 3 Effect of age on mean serum 25(OH)D concentration
Age (years) 25(OH)D nmol/L mean ± SD Range P valuea
50–59 50.95±17.40 22.9–110.9 0.002
60–69 45.21±14.59 22.0–82.0 0.582
70 and more 36.64±12.51 10.0–57.2 0.001
a Each group vs. the remaining two
Statistical difference (F=7.05, P=0.001), age 50–59 vs. age 70+ (P=0.001), age 50–59 vs. age 60–69 (P=0.197), age 60–69 vs. age 70+ (P=
0.108)
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considering that they were referred for initial screening for
osteoporosis. We did not influence the referral.
In conclusion, both studies indicate poor vitamin D
status in population of Croatian postmenopausal women
(initially screened for osteoporosis or being treated for
osteoporosis). We can speculate on reasons. Croatia is
located above 35° of latitude, which prevents the produc-
tion of vitamin D in skin from October to March. Food is
not fotificated with vitamin D in Croatia, and average
dietary intake of oily fish is very low in general population.
Also, supplements of vitamin D are usually prescribed only
to the patients with established osteoporosis, and compli-
ance is low. In our study, detected serum level of 25(OH)D
was mean (±SD) 46.94 (±16.77) nmol/L, which is
concordant with results of study conducted in Italy on
similar study population, free-living postmenopausal wom-
en referred to an osteoporosis outpatient clinic for initial
screening. They detected mean 25(OH)D level of 45±
20 nmol/L [24].
Generally, vitamin D status is negatively related to age.
Older persons are at increased risk of vitamin D inadequacy
due to the reduced capacity of older skin to synthesize
vitamin D under the influence of ultraviolet light. The risk
of vitamin D inadequacy could even be increased in
institutionalized persons due to the lower sunshine expo-
sure [25, 26]. In our study, correlation between age and
serum 25(OH)D concentration was significant and negative
(r=−0.28; P=0.002). The critical age at which the
concentration declined most strongly was 59 years, and
the prevalence of more pronounced deficiency of vitamin D
(<30 nmol/L) was very high in patient aged 65 years and
more (23.8%).
Seasonal variations in vitamin D status are expected in
countries distant from equator. There is seasonal variation
in UVB exposure because of the lower angle of the sun.
Highest prevalence of 25(OH)D deficiency can be expected
in late winter and early spring, thus concentrations of 25
(OH)D are highest in summer and early fall [27]. We also
detected the highest level of vitamin D in summer with
significant statistical difference between spring and summer
and winter and summer (P=0.015 and P=0.022).
Obesity has been found to be associated with lower
levels of serum 25(OH)D [27, 28] and higher levels of
serum PTH [29, 30]. Underlying causes that have been
suggested are less sun exposure due to the limited mobility
in obese persons and higher storage of vitamin D in adipose
tissue. The association between serum 25(OH)D and
obesity is weaker if only anthropometric measures are used
indicating specific role of adipose tissue [30]. In our study,
only anthropometric measures were used (weight, height,
and BMI), and we did not detect a significant correlation
between BMI and serum 25(OH)D concentration (r=−0.13,
P=0.157), which may be also due to the small sample size.
The results of this study are prone to several limitations.
Firstly, the study was based on the relatively small sample
size that had several implications, including the lack of
possibility to assess seasonal variation based on the
monthly data. Furthermore, the sample that was included
in the present study and analyzed might not be represen-
tative for the entire population of Croatian postmenopausal
women.
Conclusion
The results of this study suggest very high prevalence of
inadequate vitamin D concentrations in Croatian postmen-
opausal women. Since the inadequate concentration of
vitamin D may affect skeletal and nonskeletal physiological
functions, this has to be considered as an important health
risk factor, thus making this one of the public health
priorities requiring a careful approach and widespread
intervention efforts.
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